Quoin Pharmaceuticals Ltd Stock Alpha and Beta Analysis

QNRX Stock  USD 0.30  0.01  3.45%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Quoin Pharmaceuticals Ltd. It also helps investors analyze the systematic and unsystematic risks associated with investing in Quoin Pharmaceuticals over a specified time horizon. Remember, high Quoin Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Quoin Pharmaceuticals' market risk premium analysis include:
Beta
(0.79)
Alpha
(1.17)
Risk
8.28
Sharpe Ratio
(0.11)
Expected Return
(0.91)
Please note that although Quoin Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Quoin Pharmaceuticals did 1.17  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Quoin Pharmaceuticals Ltd stock's relative risk over its benchmark. Quoin Pharmaceuticals has a beta of 0.79  . As returns on the market increase, returns on owning Quoin Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Quoin Pharmaceuticals is likely to outperform the market. Book Value Per Share is likely to drop to 1,604 in 2025. Tangible Book Value Per Share is likely to drop to 1,552 in 2025.

Enterprise Value

(3.44 Billion)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Quoin Pharmaceuticals Backtesting, Quoin Pharmaceuticals Valuation, Quoin Pharmaceuticals Correlation, Quoin Pharmaceuticals Hype Analysis, Quoin Pharmaceuticals Volatility, Quoin Pharmaceuticals History and analyze Quoin Pharmaceuticals Performance.

Quoin Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Quoin Pharmaceuticals market risk premium is the additional return an investor will receive from holding Quoin Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Quoin Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Quoin Pharmaceuticals' performance over market.
α-1.17   β-0.79

Quoin Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Quoin Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Quoin Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Quoin Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Quoin Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quoin Pharmaceuticals shares will generate the highest return on investment. By understating and applying Quoin Pharmaceuticals stock market price indicators, traders can identify Quoin Pharmaceuticals position entry and exit signals to maximize returns.

Quoin Pharmaceuticals Return and Market Media

The median price of Quoin Pharmaceuticals for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 0.38 with a coefficient of variation of 36.42. The daily time series for the period is distributed with a sample standard deviation of 0.17, arithmetic mean of 0.47, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
MAIA Biotechnology Announces Private Placement of 2,715,000
02/18/2025
2
COFCO Biotechnology Co., Ltd.s Prospects Need A Boost To Lift Shares
02/24/2025
3
Seattles Nautilus Biotechnology lays off 16 percent of its staff
02/27/2025
4
Apex Biotechnology Full Year 2024 Earnings EPS Beats Expectations, Revenues Lag
03/03/2025
5
Is Sana Biotechnology Among Jeff Bezos Investments in 2025
03/04/2025
6
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635
03/05/2025
7
Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on ...
03/06/2025
8
Is Sichuan Hebang Biotechnology Using Too Much Debt
03/07/2025
9
Cizzle Biotechnology Hits New 1-Year Low Heres What Happened
03/12/2025

About Quoin Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Quoin or other stocks. Alpha measures the amount that position in Quoin Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Quoin Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Quoin Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Quoin Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Quoin Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Quoin Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Quoin Pharmaceuticals' management manipulating its earnings.
13th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Quoin Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.